Timothy Price, MBBS, DHthSc, FRACP, discusses the rationale to evaluate sotorasib in gastrointestinal cancers.
Timothy Price
Advertisement
Articles by Timothy Price
Timothy Price, MBBS, DHthSc, FRACP, discusses challenges faced during the CodeBreaK 100 trial in gastrointestinal cancers.
Timothy Price, MBBS, DHthSc, FRACP, discusses the safety and efficacy of AMG 510 in patients with advanced gastrointestinal cancers.
Advertisement
Latest Updated Articles
Dr. Price on the Safety, Efficacy of AMG 510 in Advanced Gastrointestinal CancersPublished: November 21st 2020 | Updated:
Dr. Price on the Rationale for Sotorasib in Advanced Gastrointestinal CancersPublished: December 16th 2020 | Updated:
Dr. Price on the Challenges of the CodeBreaK 100 Trial in GI CancersPublished: November 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma
5